News

Researchers have developed an approach to “deleting” a blood system affected by leukemia while simultaneously building up a new, healthy system with donor blood stem cells.

A trial HIV vaccine has triggered low levels of HIV bnAbs in humans. The findings provide proof that a vaccine can elicit bnAbs to fight diverse strains of HIV and that it can initiate the process within weeks after just two immunizations.

Re-vaccination against SARS-CoV-2 promotes the development of broadly inhibitory antibodies against a wide range of variants, which supports the use of yearly booster vaccines.

In nature, bacteria use CRISPR-Cas systems to fight off deadly viruses. A recent international collaboration has shed light on the most enigmatic CRISPR-Cas systems; the type IV system.

Scientists have engineered an adeno-associated virus (AAV) that efficiently crosses the blood-brain barrier in human cell models and delivers genes throughout the brain in humanized mice.

An estimated 40% of low-back pain cases are attributed to degeneration of the cushiony intervertebral discs that absorb shocks and provide flexibility to the spine.

Routine vaccination of young people against HPV in the UK has reduced the incidence of cervical disease across socioeconomic groups.

Immunotherapy could be used to enhance immune responses in older people, making them less vulnerable to infections, reports a new study.

In the longest clinical trial yet of semaglutide, a prescription drug sold under the brand names Wegovy and Ozempic, researchers analyzed the drug's long-term weight loss effects.

Nature gave ticks, mosquitos and leaches a quick-acting way to keep blood from clotting while they extract their meal from a host. Now the key to that method has been harnessed as a potential anti-clotting agent.